Contrast-enhanced colour Doppler ultrasonography in suspected breast cancer recurrence

British Journal of Surgery

Volumn 86, Issue 9, 1999, Pages 1198-1201

  Winehouse, J ^a   Douek, M ^a   Holz, K ^c   Madjar, H ^b   Gillams, A ^a   Lees, W ^a   Baum, M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SHU 508;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER RECURRENCE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCAR FORMATION;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMAGE ENHANCEMENT; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0032888274     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01163.x     Document Type: Article

References (16)

1. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989; 320: 822-8.
2. Fisher ER, Anderson S, Redmond C, Fisher B. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg Oncol 1992; 8: 161-6.
3. Balu-Maestro C, Bruneton JN, Geoffray A, Chauvel C, Rogopoulos A, Bittman O. Ultrasonographic posttreatment follow-up of breast cancer patients. J Ultrasound Med 1991; 10: 1-7.
4. Sickles EA, Herzhog KA. Mammography of the post-surgical breast. AJR Am J Roentgenol 1981; 136: 585-8.
5. Madjar H, Pfleiderer A, Schürmann R, Schlief R. Diagnosis by color Doppler and contrast agents. In: Figueira Fo ASS, Novais-Dias E, Salvador-Silva H, Barros ACSD, eds. Mastology - Breast Diseases. Amsterdam: Elsevier Science, 1995: 69-75.
6. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for colour Doppler US: effect on breast masses. Work in progress. Radiology 1996; 198: 679-86.
7. Huber S, Helbich T, Kettenbach J, Dock W, Zuna I, Delorme S. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US - early experience. Radiology 1998; 208: 485-9.
8. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
9. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
10. Beck R, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986; 110: 13-20.
11. Carson PL, Moskalik AP, Govil A, Roubidoux MA, Fowlkes JB, Normolle D et al. The 3D and 2D color flow display of breast masses. Ultrasound Med Biol 1997; 23: 837-49.
12. Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K et al. Breast lesions: correlation of contrast medium enhancement patterns with histopathologic findings and tumor angiogenesis. Radiology 1996; 200: 639-49.
13. Heywang-Kobrunner SH, Veiweg P, Heinig A, Kuchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997; 24: 94-108.
14. Davis PL, McCarty KS Jr. Sensitivity of enhanced MRI for the detection of breast cancer: new, multicentric, residual, and recurrent. Eur J Radiol 1997; 7(Suppl 5): 289-98.
15. Mumtaz H, Davidson T, Hall-Craggs MA, Payley M, Warmsley K, Cowley G et al. Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer. Br J Surg 1997; 84: 1147-51.
16. Turkat TJ, Klein BD, Polan RL, Richman RH. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imaging 1994; 4: 563-8.